• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 S100B 蛋白水平作为急性复发偏执型精神分裂症患者的神经炎症生物标志物。

Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients.

机构信息

Departamento de Medicina Interna, Dermatología y Psiquiatría, Facultad de Ciencias de la Salud, Universidad de La Laguna, La Laguna, Santa Cruz de Tenerife, Spain.

Consultoría Psiquiátrica SC, Santa Cruz de Tenerife, Spain.

出版信息

Acta Neuropsychiatr. 2023 Jun;35(3):138-146. doi: 10.1017/neu.2022.37. Epub 2022 Dec 12.

DOI:10.1017/neu.2022.37
PMID:36503534
Abstract

OBJECTIVE

The s100b inflammatory protein is involved in schizophrenia pathophysiology. We aim at studying the evolution of the s100b serum levels in acutely relapsed paranoid schizophrenia patients at three different time points (admission, discharge and 3 months after hospital discharge 3MAHD).

METHODS

Twenty-three paranoid schizophrenia inpatients meeting DSM-IV criteria participated in the research. Twenty-three healthy subjects matched by age, gender and season acted as the control group. Psychopathology was measured with the Positive and Negative Syndrome Scale (PANSS). Serum s100b levels were determined at 12:00 and 24:00 h with an enzyme-linked immunoassay kit.

RESULTS

Patients had significant higher serum s100b levels at admission and discharge (12:00 h) than the group of healthy subjects. At admission and discharge, s100b serum levels at 24 h had decreased compared to the 24:00 h s100b levels of the healthy subjects. At 3MAHD patients and healthy subjects had similar levels of serum s100b protein. Positive and negative PANSS scores decreased significantly between admission and discharge. Positive and negative PANSS scores decreased between discharge and 3MAHD, but these changes had no statistical significance.

CONCLUSIONS

Our study confirms that the acute inflammatory response produced in acutely relapsed patients is reversed after 3 month of hospital discharge. The variations of serum s100b concentrations when the patients suffer from an acute relapse may be a useful predictor of disease evolution.

摘要

目的

S100B 炎症蛋白与精神分裂症的病理生理学有关。我们旨在研究三种不同时间点(入院时、出院时和出院后 3 个月)急性复发偏执型精神分裂症患者的 S100B 血清水平变化。

方法

23 名符合 DSM-IV 标准的住院偏执型精神分裂症患者参与了这项研究。23 名年龄、性别和季节相匹配的健康受试者作为对照组。采用阳性和阴性综合征量表(PANSS)评估精神病理学。在 12:00 和 24:00 时使用酶联免疫试剂盒测定血清 S100B 水平。

结果

患者入院时和出院时(12:00 h)的血清 S100B 水平明显高于健康对照组。入院时和出院时,与健康对照组 24:00 h 的 S100B 水平相比,24 h 的 S100B 血清水平有所下降。在 3MAHD 时,患者和健康对照组的血清 S100B 蛋白水平相似。入院时和出院时,阳性和阴性 PANSS 评分显著降低。出院时和 3MAHD 时,阳性和阴性 PANSS 评分下降,但这些变化无统计学意义。

结论

本研究证实,急性复发患者体内产生的急性炎症反应在出院后 3 个月得到逆转。急性复发患者血清 S100B 浓度的变化可能是疾病演变的一个有用预测指标。

相似文献

1
Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients.血清 S100B 蛋白水平作为急性复发偏执型精神分裂症患者的神经炎症生物标志物。
Acta Neuropsychiatr. 2023 Jun;35(3):138-146. doi: 10.1017/neu.2022.37. Epub 2022 Dec 12.
2
Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia.急性偏执型精神分裂症患者血清S100B蛋白浓度的昼夜变化
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:207-212. doi: 10.1016/j.pnpbp.2017.02.007. Epub 2017 Feb 8.
3
Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrations.急性偏执型精神分裂症复发住院患者的血清 S100B 浓度在夏季/冬季而非白天/夜间发生变化。
Actas Esp Psiquiatr. 2021 Sep;49(5):211-215. Epub 2021 Sep 1.
4
A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE.精神分裂症中S100B的一个新的病理生理学方面:S100B被其清除剂可溶性RAGE的潜在调控
Biol Psychiatry. 2009 Jun 15;65(12):1107-10. doi: 10.1016/j.biopsych.2008.10.044. Epub 2008 Dec 21.
5
S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia.精神分裂症患者的S100B血清水平与阴性症状的长期改善
Neuropsychopharmacology. 2004 May;29(5):1004-11. doi: 10.1038/sj.npp.1300403.
6
Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels.急性发病精神分裂症患者 S100B+NK 细胞计数增加与游离皮质醇指数相关,但与 S100B 血清水平无关。
Brain Behav Immun. 2012 May;26(4):564-7. doi: 10.1016/j.bbi.2012.01.018. Epub 2012 Feb 3.
7
Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.长期服用氯氮平或传统抗精神病药物的慢性精神分裂症患者血清S100B水平升高。
Neurosci Lett. 2009 Sep 22;462(2):113-7. doi: 10.1016/j.neulet.2009.06.019. Epub 2009 Jun 17.
8
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.未接受药物治疗和已接受治疗的精神分裂症患者血液中S100B水平升高与阴性症状相关。
Mol Psychiatry. 2001 Jul;6(4):445-9. doi: 10.1038/sj.mp.4000889.
9
Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.认知功能障碍与未经药物治疗的急性复发精神分裂症患者血清 S100B 浓度升高相关。
Psychiatry Res. 2017 Jan;247:6-11. doi: 10.1016/j.psychres.2016.09.029. Epub 2016 Sep 22.
10
Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia.警报素(IL-33、sST2、HMGB1 和 S100B)作为精神分裂症的潜在生物标志物。
J Psychiatr Res. 2021 Jun;138:380-387. doi: 10.1016/j.jpsychires.2021.04.019. Epub 2021 Apr 29.

引用本文的文献

1
Neuroinflammatory Loop in Schizophrenia, Is There a Relationship with Symptoms or Cognition Decline?精神分裂症中的神经炎症循环,与症状或认知衰退有关系吗?
Int J Mol Sci. 2025 Jan 1;26(1):310. doi: 10.3390/ijms26010310.
2
Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review.五种主要精神疾病中的外周S100B蛋白水平:一项系统评价
Brain Sci. 2023 Sep 16;13(9):1334. doi: 10.3390/brainsci13091334.
3
Vascular-related biomarkers in psychosis: a systematic review and meta-analysis.精神病中与血管相关的生物标志物:系统评价与荟萃分析。
Front Psychiatry. 2023 Aug 25;14:1241422. doi: 10.3389/fpsyt.2023.1241422. eCollection 2023.
4
Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs.S100B 是否与注意缺陷多动障碍(ADHD)有关?与对照组的比较以及含哌醋甲酯、褪黑素和 ω-3 PUFAs 的三联疗法后的变化。
Nutrients. 2023 Jan 31;15(3):712. doi: 10.3390/nu15030712.